Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MARGENZA safely and effectively. See full prescribing information for MARGENZA. MARGENZA® (margetuximab-cmkb) injection, for intravenous use Initial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
MARGENZA is indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease [see Dosage and Administration (2.1) and Clinical Studies (14.1)].
- generic_name
- margetuximab-cmkb
- product_names
- margetuximab-cmkb
- ndc
- 74527-022, 74527-022-01, 74527-022-02, 74527-022-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en